Avastin and Malignant Gliomas

Avastin and Malignant Gliomas avastin Avastin injection is a clear to slightly opalescent, colorless to pale brown, sterile solution for intravenous infusion supplied as single-dose avastin Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific

avastin Avastin is approved to treat metastatic colorectal cancer for: First- or second-line treatment in combination with intravenous fluorouracil–based

avastin In 1997, clinical trials of Avastin began The main trial upon which FDA approval was based was a Phase III trial involving 813 patients The Avastin is designed to prolong life by controlling advanced cervical cancer, rather than treating it Research suggests that Avastin can add